Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商電化生研股份有限公司filedCritical日商電化生研股份有限公司
Priority to TW107306537D01FpriorityCriticalpatent/TWD198369S/en
Publication of TWD198369SpublicationCriticalpatent/TWD198369S/en
【物品用途】;本設計之物品係如顯示使用狀態之參考圖所示，藉由插入裝有來自血液等體液成分之檢體的檢查匣，可檢測或定量被檢物質並進行生物體資訊之分析者。;【設計說明】;以紅色著色之部分為本案不主張設計之部分。包含立體圖在內特定出本案主張設計之部分。於各圖中，表面部整面所示之濃淡均係用以特定出立體表面之形狀者。;本案設計係新穎獨特之樣式，藉由獨特地設計檢體分析機，可顯現出先前技藝所未有之視覺效果。[Usage of the article]: This designed article, as shown in the reference picture showing the usage status, can detect or quantify the substance to be inspected and conduct biological information by inserting a test cassette containing a sample from body fluid components such as blood. Analyst. ;[Design Description];The parts colored in red are the parts that are not designed in this case. Including three-dimensional drawings, the parts of the proposed design of this case are specified. In each figure, the shades shown throughout the surface are used to specify the shape of the three-dimensional surface. ;The design of this case is a novel and unique style. By uniquely designing the specimen analysis machine, it can show visual effects that were unprecedented in previous techniques.
method for preparing a sample, homogenized composition, methods for generating data, for treating a disease, identifying a marker, for determining the prognosis of a cancer, for determining a phenotypic profile, for storing the homogenized composition, for preparing a sample for fabric and prepare the homogenized composition
KIT TO DETECT AN ANALYTE OF INTEREST IN A PLURALITY OF BIOLOGICAL LIQUID SAMPLES, METHOD TO DETECT AND/OR QUANTIFY IT AND CARTRIDGE TO PERFORM SUCH METHOD
MULTIPARAMETRIC DIAGNOSTIC TEST SYSTEM FOR THE DETECTION AND MONITORING OF THERAPY OF BREAST CANCER AND OVARIAN CANCER, AND METHOD FOR ANALYSIS WITH ITS USE
isolated monoclonal antibody, method for measuring the level of gamma-glutamyl-l-epsilon-lysine (gel), ex vivo method for monitoring apoptosis, use of a specific monoclonal antibody for gamma-glutamyl-l-epsilon-lysine (gel) ), methods for monitoring the efficacy of apoptosis-inducing treatment, method of treating an unregulated apoptosis-associated disease, apoptosis monitoring kit, sepsis treatment method, and side-flow immunoassay device